| YANA - YOU ARE NOT ALONE NOW PROSTATE CANCER SUPPORT SITE HOMEPAGE LINKS : EXPERIENCES : DISCUSSION FORUM : TROOP C : ABOUT US : JOIN US : UPDATE YOUR STORY : MAIL US Acknowledgment and thanks are due to Eric Taylor, Australian Mentor for YANA, who created this and the other Charts. | |||||||||||||
| TREATMENT EXPERIENCES
| Most people are looking for information about one specific type of treatment, so the stories are initially grouped and indexed by:
It is also possible to see some of the stories indexed by country of residence. In the case of the USA, some entries are indexed by State of residence. In time all will show State of residence. The link is PLACE NAME TABLE The stories of men newly diagnosed men are here These are the links to the stories by treatment:
| ||||||||||||
|
Primary
Treatment
|
Further treatment, if any, with current PSA |
Name | |||||||||||
|
Date |
Age |
PSA |
GS |
Stage |
PSA |
Treatment/SideEffects
| Date | ||||||
NEWLY
DIAGNOSED/UNDECIDED | |||||||||||||
Apr-10 | 60 | 14.0 | 6 | T1c | Undecided | - | - | Jun-10 | |||||
Jul-10 | 59 | 11.0 | 8 | T1c | Undecided | - | - | Aug-10 | |||||
| Mar-10 |
55 |
4.7 |
6 |
T1c |
Undecided |
- |
- |
Apr-10 | |||||
|
Dec-09 |
48 |
6.4 |
6 |
T1c |
Undecided |
- |
- |
Dec-09 | |||||
Sep-09 | 54 | 12.0 | 6 | T1c | Undecided | - | - | Jan-10 | |||||
Jun-09 | 54 | 21.0 | 6 | T1c | Undecided | - | - | Jan-10 | |||||
Mar-10 | 51 | 3.8 | 6 | T1c | Undecided | - | - | Apr-10 | |||||
Jul-10 | 58 | 5.7 | 6 | T1c | Undecided | - | - | Aug-10 | |||||
Apr-08 | 66 | 7.0 | 6 | T1c | Undecided | - | Consider
ADT/Brachy | Jun-10 | |||||
May-10 | 56 | 2.58 | 6 | T1c | Undecided | - | - | Jun-10 | |||||
Jul-09 | 67 | 8.4 | 6 | T1c | Undecided | - | - | Oct-09 | |||||
Nov-09 | 49 | 1.99 | 6 | T1c | Undecided | - | - | Dec-09 | |||||
Mar-10 | 52 | 10.9 | 7 | T1c | Undecided | - | - | Jun-10 | |||||
Apr-10 | 58 | 3.8 | 6 | T1c | Undecided | - | ?
Focal cryotherapy | Jun-10 | |||||
Jun-10 | 67 | 4.3 | 6 | T1c | Undecided | - | ?
Brachytherapy | Aug-10 | |||||
May-10 | 55 | 1.8 | 6 | T2a | Undecided | - | - | Jun-10 | |||||
Jan-10 | 62 | 6.1 | 7 | T1c | Undecided | - | - | Mar-10 | |||||
Jun-10 | 60 | 1.4 | 7 | T1c | Undecided | - | - | Jun-10 | |||||
Jan-10 | 73 | 8.7 | 6 | T1c | Undecided | - | - | Mar-10 | |||||
Jul-10 | 78 | 25.33 | 7 | T1c | Undecided | - | - | Aug-10 | |||||
Aug-10 | 60 | 3.2 | 6 | T1c | Undecided | - | - | Aug-10 | |||||
Jan-10 | 59 | 15.1 | 7 | T1c | Undecided | - | - | Feb-10 | |||||
Aug-09 | 65 | 3.3 | 8 | T2b | Undecided | - | - | Sep-09 | |||||
Jun-10 | 45 | 4.68 | 6 | T1c | Undecided | - | - | Jun-10 | |||||
|
Primary
Treatment
|
Further
treatment, if any, with current PSA |
Name | |||||||||||
|
Date |
Age |
PSA |
GS |
Stage |
PSA |
Treatment/SideEffects
| Date | ||||||
ACTIVE
SURVEILLANCE - WATCHFUL WAITING | |||||||||||||
Aug-08 | 63 | 6.83 | 6 | T1c | Active
Surveillance | 4.6 | - | Dec-09 | |||||
|
May-04 |
65 |
5.7 |
6 |
T1c |
Active
Surveillance | 2.5 |
Cancer
Free/BPH | Nov-09 | |||||
Dec-07 | 56 | 5.24 | 6 | T1c | Active
Surveillance | 3.99 | Cryotherapy | Feb-09 | |||||
Oct-05 | 49 | 2.1 | 6 | T1c | Active
Surveillance | 0.6 | Cancer
Free | Jan-10 | |||||
Aug-08 | 61 | 10.0 | 7 | T1c | Active
Surveillance | Undetec | Surgery | Jan-10 | |||||
| Mar-03 |
60 |
4.5 |
6 |
T1c |
Watch
& Wait |
8.4 |
Supplements |
Jul-09 | |||||
Jun-08 | 73 | 4.1 | 7 | T1b | Active
Surveillance | 0.50 | Cancer
Free | Dec-09 | |||||
Nov-08 | 56 | 3.3 | 6 | T1c | Active
Surveillance | 3.4 | Negative
biopsy | Aug-10 | |||||
Jun-09 | 54 | 4.7 | 6 | T1b | Watch
& Wait | 3.5 | No
issues | Jun-10 | |||||
| May-03 |
47 |
4.59 |
6 |
T1c |
Active
Surveillance |
5.68 |
AS |
Jun-10 | |||||
Oct-09 | 67 | 4.6 | 6 | T1c | Active
Surveillance | 3.2 | Lifestyle
and diet | Jun-10 | |||||
Jul-06 | 67 | 12.8 | 6 | T1c | Active
Surveillance | 4.5 | Cancer
Free | Dec-09 | |||||
| Jul-99 |
53 |
5.4 |
6 |
T1c |
Alternative |
+-
2.0 |
Human
milk |
Sep-09 | |||||
Oct-02 | 52 | 6.7 | 5 | T1c | Active
Surveillance | 5.3 | Brachytherapy | Nov-09 | |||||
Feb-98 | 60 | 4.4 | 6 | T1c | Active
Surveillance | 3.6 | Lifestyle
and diet | Feb-10 | |||||
Nov-09 | 52 | 3.8 | 6 | T1c | Watch
& Wait | 1.3 | No
support for AS | Jul-10 | |||||
| Mar-04 |
64 |
6.0 |
7 |
T1c |
Watch
& Wait |
0.47 |
ProstRcision®:
ED |
Jul-10
| |||||
Mar-10 | 49 | 5.6 | 6 | T1c | Watch
& Wait | 5.7 | - | Aug-10 | |||||
| Aug-08 |
67 |
9.77 |
7 |
T1c |
Active
Surveillance |
6.72 |
Supplements |
Jul-10 | |||||
Apr-06 | 54 | 4.4 | 6 | T1c | Active
Surveillance | No
response to reminder | Mar-08 | ||||||
Dec-06 | 55 | 5.8 | 6 | T1c | Watch
Wait | 1.2 | Proton
Beam | Jun-10 | |||||
Aug-07 | 62 | 3.0 | 6 | T1c | Active
Surveillance | 2.8 | Surgery | Oct-08 | |||||
Nov-09 | 55 | 10.0 | 6 | T1c | Active
Surveillance | 6.7 | 4th
biopsy positive | Aug-10 | |||||
Apr-06 | 66 | 6.0 | 6 | T1c | Watch
& Wait | 8.3 | Watch
& Wait | Nov-09 | |||||
Jun-00 | 72 | 5.6 | 6 | T1c | Watch
& Wait | 0.12 | ADT/IMRT | Mar-10 | |||||
Jan-10 | 49 | 3.37 | 6 | T1c | Active
Surveillance | 1.45 | - | Jun-10 | |||||
Nov-08 | 67 | <
4.0 | 7 | T1a | Active
Surveillance | 0.86 | ActiveSurveillance | Dec-09 | |||||
Nov-07 | 57 | 5.4 | 6 | T1c | Active
Surveillance | 4.6 | - | Nov-09 | |||||
Jul-09 | 48 | 3.0 | 6 | T1c | Active
Surveillance | 0.55 | - | Jul-10 | |||||
Nov-09 | 46 | 4.7 | 6 | T1c | Active
Surveillance | 4.6 | Diet
and exercise | Jul-10 | |||||
Nov-09 | 67 | 5.0 | 6 | T1c | Active
Surveillance | 4.2 | - | Jan-10 | |||||
Jun-08 | 57 | 9.1 | 6 | T2b | Active
Surveillance | 7.5 | - | Feb-09 | |||||
Jun-02 | 59 | 2.2 | 7 | ? | Watch
Wait/Experimental | Passed
on - RIP | Jul-10 | ||||||
Jan-98 | 68 | 5.5 | 5 | T1c | Watch
Wait | 20.0 | Prostatsol | Jun-09 | |||||
Mar-09 | 59 | 2.9 | 6 | T1c | Active
Surveillance | 2.1 | No
cancer found | Jun-10 | |||||
| Aug-96 |
54 |
7.2 |
7 |
T2b |
Watch & Wait |
2.30 |
Inter ADT:on in Jun'10 |
Aug-10 | |||||
Oct-06 | 52 | 4.3 | 6 | T1c | Active
Surveillance | 4.6 | AS | Dec-09 | |||||
Oct-03 | 62 | 6.1 | 6 | T1c | Watch
& Wait/Prostasol | 9.7 | Brachy/ADT | Apr-10 | |||||
Aug-06 | 57 | 15.0 | 5 | T1a | Active
Surveillance | 0.30 | Finasteride | Aug-09 | |||||
Nov-08 | 56 | 3.8 | 6 | T1c | Active
Surveillance | 3.01 | - | Jan-10 | |||||
May-08 | 58 | 7.7 | 6 | T1c | Active
Surveillance | 4.7 | No
cancer found | Jun-10 | |||||
Jul-07 | 52 | 4.5 | - | - | Active
Surveillance | 6.6 | Diet
& Lifestyle | Nov-08 | |||||
Nov-95 | 48 | 60.0 | 7 | T1c | Watch/Wait | Passed
on - RIP | Sep-07 | ||||||
Jan-94 | 58 | 20.0 | 5 | T2 | Active
Surveillance | Rising | Change
Lifestyle | May-09 | |||||
Jan-09 | 61 | 10.5 | 6 | T1c | Active
Surveillance | 16.4 | Herbs
and diet | Aug-10 | |||||
Jun-07 | 50 | 3.9 | 7 | T1c | Active
Surveillance | 2.0 | Diet/Exercise | Dec-08 | |||||
Mar-09 | 63 | 6.5 | ? | T1c | Active
Surveillance | 13.5 | - | Aug-09 | |||||
Nov-09 | 51 | 5.9 | 6 | T1c | Active
Surveillance | 5.9 | Supplements/diet | Jul-10 | |||||
Nov-07 | 64 | 5.3 | 6 | T1c | Active
Surveillance | 6.3 | Some
ED | Mar-10 | |||||
Jun-09 | 58 | 12.5 | 6 | T1c | Active
Surveillance | 5.2 | - | Oct-09 | |||||
Dec-08 | 61 | 1.54 | 6 | T2a | Active
Surveillance | 1.33 | - | Jun-10 | |||||
| Oct-00 |
64 |
7.3 |
? |
? |
Watch
Wait | 51.0 |
Watch & Wait |
Sep-10 | |||||
Feb-06 | 58 | 4.4 | 6 | T1c | Watch
Wait/Surgery | No
response to reminder | Oct-08 | ||||||
| Nov-02 |
60 |
5.0 |
6 |
T1c |
Watch & Wait |
<0.1 | EBRT:
ED; leakage |
Jul-10 | |||||
| May-05 |
61 |
1.4 |
6 |
T2b |
Watch
& Wait | 3.4 |
Watch
& Wait |
Jul-10 | |||||
Nov-08 | 57 | 4.7 | 6 | T1c | Active
Surveillance | 4.0 | 3rd
negative biopsy | Apr-10 | |||||
Nov-09 | 58 | 0.73 | 6 | T2a | Active
Surveillance | 0.48 | Diet
and exercise | Jul-10 | |||||
| Oct-09 |
63 |
14.1 |
6 |
T1c |
Active
Surveillance | 14.3 |
Cancer
free |
Jan-10 | |||||
Apr-10 | 46 | 6.5 | 6 | T2a | Active
Surveillance | - | - | Aug-10 | |||||
Jun-04 | 50 | 3.8 | 6 | T1c | Active
Surveillance | 3.4 | - | Sep-09 | |||||
May-06 | 63 | 5.4 | 6 | T1c | Active
Surveillance | 6.4 | - | Jun-10 | |||||
Jan-10 | 66 | 1.19 | 6 | T2a | Active
Surveillance | 0.67 | - | Jul-10 | |||||
Sep-09 | 62 | 6.1 | 6 | T1c | Active
Surveillance | - | - | Jan-10 | |||||
|
Aug-05 |
51 |
6.5 |
6 |
T1c |
Active
Surveillance | ? |
Awaiting
biopsy | Aug-10 | |||||
Jan-98 | 76 | 11.0 | 6 | T1c | Watch
& Wait | Passed
on - RIP | Jul-00 | ||||||
Nov-05 | 54 | 0.50 | 6 | T1a | Active
Surveillance | 0.60 | Active
Surveillance | May-09 | |||||
|
Apr-05 |
66 |
2.14 |
6 |
T1c |
Watch
& Wait | 2.78 |
Watch
& Wait |
Oct-09 | |||||
Apr-08 | 59 | 3.2 | 6 | T1c | Active
Surveillance | 1.2 | Finasteride | May-09 | |||||
May-07 | 52 | 12.2 | 6 | T1c | Active
Surveillance | 37.0 | - | May-09 | |||||
Dec-09 | 62 | 3.9 | 6 | T1c | Active
Surveillance | - | - | Jan-10 | |||||
Jan-09 | 58 | 6.1 | 6 | T1c | Active
Surveillance | 2.5 | Proscar | Jul-09 | |||||
Oct-07 | 51 | 3.3 | 6 | T2a | Active
Surveillance | 2.3 | Surgery | Mar-09 | |||||
Feb-08 | 52 | 4.19 | 7 | T1c | Active
Surveillance | 4.5 | - | Jun-10 | |||||
Sep-09 | 40 | 1.4 | 6 | T1c | Active
Surveillance | 1.4 | Cancer
Free | Apr-09 | |||||
Oct-07 | 60 | 4.2 | 6 | T1c | Active
Surveillance | 2.6 | Cancer
Free | Feb-09 | |||||
Jan-08 | 52 | 0.90 | 6 | T1c | Active
Surveillance | 0.80 | 2nd
biopsy negative | Aug-10 | |||||
| Nov-01 |
62 |
6.9 |
6 |
T1c |
Active
Surveillance |
14.2 |
Diet/supplements
| Jul-10 | |||||
Jul-09 | 57 | 7.5 | 6 | T1c | Active
Surveillance | ? | Diet:2nd
biopsy neg | Aug-10 | |||||
| Jan-09 |
70 |
7.2 |
6 |
T1c |
| 4.6 |
- |
Jun-10 | |||||
Oct-07 | 67 | 4.75 | 6 | T1c | 2.78 | - | Aug-10 | ||||||
Feb-08 | 65 | 7.5 | 6 | T1c | Active
Surveillance | Unknown | ADT/EBRT/SI | Aug-09 | |||||
|
Feb-09 |
52 |
3.0 |
6 |
T1c |
Active
Surveillance |
3.4 |
AS |
Jul-10 | |||||
Oct-06 | 61 | 5.2 | 6 | T1c | 6.4 | - | Jun-10 | ||||||
Jan-06 | 54 | 5.2 | 6 | T1c | Watchful
Waiting | 7.1 | - | May-09 | |||||
Dec-96 | 76 | 8.7 | 7 | T1c | Watchful
Waiting | 13.5 | Finasteride/ADT | Aug-10 | |||||
Sep-09 | 70 | 10.0 | 7 | T1c | Watchful
Waiting | 10.1 | Diet | Feb-10 | |||||
Apr-97 | 78 | 5.6 | 6 | T1c | Watchful
Waiting | 1.9 | Proton
Beam No SE | Mar-10 | |||||
Jul-08 | 69 | 4.6 | 6 | T2a | Active
Surveillance | 3.3 | - | Jan-09 | |||||
Jun-07 | 61 | 6.4 | 6 | T1c | Watchful
Waiting | 6.1 | Glutathione:
ED/Contin | Jan-10 | |||||
Mar-07 | 56 | 19.0 | 6 | T1c | Watchful
Waiting | 6.5 | Alkaline
Diet | Jun-10 | |||||
Nov-07 | 65 | 2.69 | 6 | T1c | Active
Surveillance | 5.0 | IMRT | May-09 | |||||
May-07 | 58 | 2.5 | 6 | T2a | Active
Surveillance | - | Focal
Cryotherapy | Oct-08 | |||||
|
Primary
Treatment
|
Further treatment, if any, with current PSA |
Name | |||||||||||
|
Date |
Age |
PSA |
GS |
Stage |
PSA |
Treatment/SideEffects
| Date | ||||||
ADT
- ANDROGEN DEPRIVATION THERAPY | |||||||||||||
Oct-08 | 40 | 41.0 | 8 | T4 | ADT | <
1.0 | Surgery/ADT | Jul-10 | |||||
Feb-07 | 55 | 9.0 | 9 | T4 | ADT | 0.38 | ADT | May-08 | |||||
Feb-07 | 55 | 9.0 | 9 | T4 | ADT | Passed
On - RIP | Sep-10 | ||||||
Jun-10 | 68 | 1,450.0 | 9 | T1a | ADT/Chemotherapy | 55.0 | No
side effects | Aug-10 | |||||
Sep-06 | 66 | 3,568 | ? | T4 | ADT | No
response to reminder | Jan-08 | ||||||
|
Sep-09 |
46 |
80.0 |
8 |
T3 |
ADT |
5.0 |
ADT |
Jul-09 | |||||
| Jan-03 |
52 |
2,100 |
9 |
T4 |
ADT |
1,002.0 |
Red
Wine/ADT |
Sep-09 | |||||
Sep-07 | 64 | 62.3 | 9 | T3 | ADT | 1.20 | EBRT/ADT | Aug-10 | |||||
Jan-10 | 69 | 1,000+ | ? | T4 | ADT | 68.0 | ADT | Mar-10 | |||||
Oct-07 | 54 | 27.5 | 7 | T1c | ADT | 1.4 | ADT/EBRT/Chemo | Aug-09 | |||||
Jan-08 | 63 | 91.6 | 9 | T4 | ADT | 0.05 | ADT | Aug-09 | |||||
Mar-08 | 62 | 459.0 | 9 | T3 | ADT | 217.0 | Chemo/DES/Trial | Aug-10 | |||||
Apr-08 | 63 | 127.0 | ? | T4 | ADT | Passed
On - RIP | Sep-09 | ||||||
Feb-05 | 42 | 219.0 | 8 | T4 | ADT | 88.0 | Chemotherapy | Aug-09 | |||||
Dec-07 | 65 | 1,121.0 | 7 | T4 | ADT | 26.0 | Intermit
ADT | Dec-09 | |||||
Apr-07 | 45 | 31.0 | 8 | T4 | ADT | Passed
On - RIP | Dec-09 | ||||||
May-02 | 62 | 5.0 | 8 | T3 | EBRT/ADT | 1.1 | Abiraterone:Eye
prob | Aug-10 | |||||
Jun-05 | 78 | 11.1 | 7 | T2c | ADT | 0.10 | ADT | Jun-09 | |||||
Mar-06 | 48 | 433.0 | ? | T4 | ADT/Chemotherapy | Passed
On - RIP | Dec-07 | ||||||
Jul-10 | 55 | 3,970.0 | 6 | T4 | ADT | - | - | Aug-10 | |||||
Nov-07 | 57 | 10.0 | 8 | T4 | ADT | Passed
On - RIP | Jun-10 | ||||||
| Dec-02 |
58 |
421.0 |
8 |
T4 |
ADT |
0.90 |
Chemotherapy |
Feb-10 | |||||
Jun-07 | 54 | 220.0 | 6 | T1c | ADT | Passed
On - RIP | Nov-08 | ||||||
Jul-06 | 72 | 24.0 | 10 | T3 | ADT |
Passed
On - RIP | Aug-10 | ||||||
Apr-09 | 72 | 47.0 | 9 | T4 | ADT | - | - | May-09 | |||||
Aug-08 | 62 | 299.0 | ? | T4 | ADT | 1.8 | ADT | Mar-10 | |||||
Feb-05 | 63 | 42.0 | 9 | T4 | ADT | 2.2 | TAK700
Trial | Nov-09 | |||||
Nov-08 | 52 | 2,520.0 | 9 | T4 | ADT | 723.0 | Chemotherapy | Jun-10 | |||||
Apr-07 | 68 | 4.0 | 9 | T4 | ADT | No
response to reminder | Oct-08 | ||||||
Jan-96 | 58 | 110.0 | 7 | T4 | ADT | 3.6
| Inter
ADT/Chemo | Jul-10 | |||||
Sep-06 | 82 | 35.0 | ? | T1c | ADT
(Orchiectomy) | No
response to reminder | Sep-08 | ||||||
Aug-08 | 50 | 375.0 | 8 | D2 | ADT | 420.0 |
Chemotherapy | Nov-09 | |||||
Dec-08 | 47 | 1,500.0 | 9 | T4 | ADT | 33.4 |
Trial | Sep-09 | |||||
May-09 | 63 | 286.0 | 8 | T4 | ADT | 0.35 | Signs
of retreat | Jun-10 | |||||
Mar-09 | 78 | 23.4 | 9 | T1c | ADT
(Eligard) | 1.4 | - | Jun-09 | |||||
Nov-08 | 72 | 42.0 | 8 | T1c | ADT/EBRT | - | - | Jan-09 | |||||
Jan-07 | 66 | 25.7 | 7 | T3 | Intermittent
ADT | 8.29 |
ADT/EBRT | Jul-10 | |||||
Apr-07 | 56 | 960.0 | ? | T4 | ADT | 42.0 | ADT2 | Aug-10 | |||||
Sep-03 | 69 | 57.0 | 7 | T4 | ADT | Passed
On - RIP | Jun-08 | ||||||
Apr-08 | 58 | 98.0 | 8 | T4 | ADT | 42.0 | ADT/EBRT/Chemo | Sep-10 | |||||
Feb-08 | 51 | 153.0 | 7 | T3b | ADT | 40.0
| Clinical
Trial - Degarelix | Mar-10 | |||||
Sep-07 | 65 | 4.6 | 9 | T3a | ADT/EBRT/Chemo/HDR | 0.03 | - | Aug-09 | |||||
May-09 | 59 | 150.0 | 7 | T4 | ADT | - | - | Aug-10 | |||||
Mar-09 | 50 | 179.0 | ? | T4 | ADT | 0.05
| - | Jan-10 | |||||
Mar-08 | 55 | 30.0 | 9 | T4 | ADT | 1.14 | ADT | Sep-09 | |||||
Oct-06 | 46 | 63.0 | 7 | T4M1 | ADT | Chemo
failed - mets spread | Jun-10 | ||||||
Jan-10 | 59 | 8.1 | 6 | T4 | ADT
- Orchidectomy | -
| Casodex | Feb-10 | |||||
| Jan-05 |
50 |
206.6 |
9 |
T3 |
ADT | Passed
On - RIP | Nov-08 | ||||||
Jun-05 | 57 | 133.0 | 7 | T3a | ADT | Passed
On - RIP | Jun-10 | ||||||
| May-09 |
51 |
362.0 |
9 |
T4 |
ADT | 157.0 | ADT3 |
Apr-10 | |||||
Jan-09 | 57 | 22.5 | 10 | T4 | ADT | 3.3 | ADT/Diet | Jul-10 | |||||
Jan-08 | 52 | 146.0 | 9 | T4 | ADT | 18.5 | Intermittent/Diet | Mar-10 | |||||
Jun-06 | 42 | 3,216.12 | 7 | T4 | ADT | 6.0 | Intermittent
ADT | Aug-10 | |||||
| Dec-99 |
59 |
4,212.0 |
7 |
T4 | ADT | Passed
On - RIP | Aug-09 | ||||||
|
Jan-09 |
54 |
564.0 |
9 |
T4 |
ADT | 1.0 | ADT |
Aug-09 | |||||
|
Jun-09 |
69 |
42.0 |
8 |
T4 |
ADT | - | EBRT/ADT |
Oct-09 | |||||
Nov-98 | 68 | 14.6 | 6 | T1c | ADT | 0.25 | Inter
ADT: POM juice | Sep-10 | |||||
May-06 | 57 | 70.0 | 10 | T3 | ADT | 0.05 | Intermit
ADT | Oct-09 | |||||
Dec-08 | 63 | 2,000.0 | 10 | T4 | ADT | 285.0 | ADT/Chemotherapy | Aug-10 | |||||
Oct-08 | 67 | 141.0 | 8 | T4 | ADT | 8.8 | ADT | Jul-09 | |||||
Jun-07 | 61 | 19.8 | 6 | T1c | Intermit
ADT3 | 9.84 | Alternative
therapies | Sep-10 | |||||
Aug-04 | 60 | 333.0 | 9 | T4 | ADT | 2.6 | ADT | Jun-09 | |||||
Dec-08 | 55 | 1,448.0 | ? | T4 | ADT | 13.3 |
ADT/Alternatives | Nov-09 | |||||
Aug-05 | 61 | 24.0 | 8 | T4M | ADT
| 1.90 | ADT/Natural | Jun-10 | |||||
Dec-08 | 65 | 13.0 | 8 | T4 | ADT
| 0.14 | EBRT/Brachytherapy | Nov-09 | |||||
Apr-09 | 75 | 1,892.0 | ? | T4 | ADT/Orchiectomy
| Passed
On - RIP | Mar-10 | ||||||
May-08 | 71 | 16.0 | ? | T3 | ADT
| - | ADT | Aug-09 | |||||
Jul-08 | 72 | 7,000.0 | 10 | T4 | ADT
| 72.0 | ADT
- ? trial | Jul-10 | |||||
Sep-06 | 59 | 435.0 | 9 | T4 | ADT | 734.0 | Chemotherapy | Dec-08 | |||||
Sep-08 | 39 | 68.0 | 9 | T4 | ADT
| <0.40 | ADT | Oct-09 | |||||
Jul-07 | 69 | 322.7 | 9 | T4 | ADT | No
response to reminder | Dec-07 | ||||||
|
Primary
Treatment
|
Further
treatment, if any, with current PSA |
Name | |||||||||||
|
Date |
Age |
PSA |
GS |
Stage |
PSA |
Treatment/SideEffects
| Date | ||||||
RADIATION
- BRACHYTHERAPY | |||||||||||||
May-08 | 51 | 9.3 | 6 | T1c | Brachytherapy/EBRT | 3.2 | - | Jan-09 | |||||
Oct-09 | 46 | 4.1 | 7 | T1c | Brachytherapy | - | No
Problems | Feb-10 | |||||
Jun-05 | 67 | 11.0 | 6 | T2c | HDR
Brachytherapy | <0.05 | - | Oct-09 | |||||
Apr-07 | 52 | 4.98 | 6 | T1c | Brachytherapy | 3.20 | PSA
rising | Dec-09 | |||||
Aug-07 | 59 | 5.8 | 6 | T1c | Brachytherapy | 0.30 | No
problems | Jun-10 | |||||
| Jan-04 |
62 |
4.6 |
6 |
T1c |
Brachytherapy |
0.04 |
- |
May-09 | |||||
Jun-07 | 63 | 31.0 | 8 | T1c | Brachy/ADT/EBRT | <0.05
| No
SE mentioned | Jul-10 | |||||
Oct-09 | 75 | 4.5 | 6 | T1c | Brachytherapy | 0.26 | Some
urinary/ED issues | Jun-10 | |||||
Dec-09 | 68 | 3.85 | 6 | T1c | Brachytherapy | 2.50 | No
problems | Jun-10 | |||||
Aug-09 | 53 | 6.0 | 6 | T1c | Brachytherapy | 0.75 | Re-seed:ED/urinary
| Apr-10 | |||||
Apr-06 | 64 | 7.7 | 6 | T1c | Brachytherapy/IMRT | 0.055 | No
SE mentioned | Mar-10 | |||||
Jul-09 | 64 | 6.8 | 6 | T1c | Brachytherapy | 0.90 | Some
urinary issues | Mar-10 | |||||
Dec-08 | 73 | 10.5 | 9 | T1c | Brachytherapy/ADT | - | - | Jan-09 | |||||
Oct-09 | 61 | 4.78 | 6 | T1c | ADT/Brachytherapy | - | No
side effects | Apr-10 | |||||
May-09 | 70 | 7.8 | 7 | T1c | ADT/Brachytherapy | - | - | Jan-10 | |||||
Dec-05 | 66 | 8.7 | 8 | T1c | Brachytherapy | 0.01 | ED | Dec-09 | |||||
|
Jan-04 |
66 |
4.0 |
6 |
T1c |
Brachtherapy |
No
response to reminder | Aug-08 | ||||||
May-05 | 69 | 4.7 | 6 | T1c | Brachytherapy | 0.565 | ED:
bladder now OK | Feb-10 | |||||
Dec-07 | 47 | 3.6 | 6 | T1c | ProstRcision® | - | - | Aug-09 | |||||
Nov-03 | 64 | 6.0 | 6 | T1c | Brachytherapy | 0.30
| Diet;exercise
| Jul-08 | |||||
Feb-03 | 55 | 6.9 | 6 | T1c | Brachytherapy | 0.06 | Slight
proctitis | Aug-10 | |||||
| Nov-97 |
59 |
5.6 |
7 |
T1c |
Brachy/EBRT |
0.10 |
None |
Aug-10 | |||||
Feb-07 | 70 | 3.97 | 6 | T2a | Brachy
+ IMRT |
No
response to reminder | Aug-08 | ||||||
|
Dec-03 |
56 |
21.0 |
9 |
T2c |
HDR
Brachytherapy |
0.06 |
ADT |
Mar-10 | |||||
Mar-09 | 50 | 5.81 | 7 | T1c | Brachytherapy | 0.68 | No
problems | Jun-10 | |||||
May-10 | 49 | 3.9 | 6 | T1c | HDR
Brachytherapy | - | - | Aug-10 | |||||
| Jul-99 |
55 |
8.9 |
6 |
T1c |
HDR Brachy/EBRT |
6.7 |
ADT |
Mar-10 | |||||
| Oct-02 |
70 |
8.0 |
6 |
T1c |
Brachytherapy |
Passed
On - RIP | Apr-05 | ||||||
Jul-07 | 67 | 5.29 | 7 | T2a | Brachytherapy | No
response to reminder | Sep-07 | ||||||
Apr-09 | 71 | 5.9 | 6 | T1c | Brachytherapy | 0.86 | - | Nov-09 | |||||
Oct-09 | 57 | 9.4 | 6 | T1c | Brachytherapy | ? | Some
urinary/ED | Feb-10 | |||||
|
Dec-07 |
68 |
<4.0 |
9 |
T3 |
ADT/EBRT/HDR
Brachy | ? |
ED
| Aug-10 | |||||
| Mar-05 |
58 |
4.0 |
6 |
T2b |
Brachytherapy |
0.10 |
-
| May-09 | |||||
|
Apr-08 |
62 |
3.39 |
7 |
T1c |
ADT/IMRT/Brachy |
Undetect |
Cialis
helps ED | Feb-10 | |||||
Jun-09 | 65 | 4.7 | 6 | T2a | Brachytherapy | 1.10 | Slight
urinary problems | Mar-10 | |||||
|
Dec-07 |
48 |
4.3 |
6 |
T1c |
Brachytherapy |
Undetect |
Surgery/ADT
| Jul-09 | |||||
Jun-08 | 61 | 4.8 | 6 | T1c | Brachytherapy
(SI) | 2.37 | - | May-09 | |||||
Mar-07 | 67 | 11.3 | 6 | T1c | Brachytherapy | 1.10 | Urinary
probs gone | Jun-10 | |||||
Jun-09 | 56 | 4.1 | 7 | T2c | ADT/Brachy/EBRT | 0.85 | Waiting
for EBRT | Apr-10 | |||||
|
Mar-97 |
59 |
4.5 |
5 |
T1c |
ADT/Brachy(HDR) |
Undet. |
None |
Dec-09 | |||||
Oct-06 | 51 | 36.6 | 6 | T1c | ProstRcision® | 0.08 | None | Jan-10 | |||||
| Aug-99 |
57 |
4.4 |
6 |
T1c |
Brachytherapy/ADT |
0.06 |
-
| May-09 | |||||
Jul-06 | 52 | 1.9 | 6 | T2a | Brachytherapy | <1.0 | - | Nov-09 | |||||
| Jun-06 |
55 |
34.0 |
9 |
T2c |
ADT/HDR
Brachy/EBRT |
105.0 |
Clinical
trial | Jan-10 | |||||
Aug-07 | 68 | 5.2 | 6 | T1c | Brachytherapy/IMRT | 0.70 | Bouncing
PSA | Jul-10 | |||||
Apr-07 | 50 | 4.1 | 6 | T1c | HDR
Brachytherapy | 0.70 | Small
cont. issues | Apr-10 | |||||
Jun-10 | 64 | 4.64 | 6 | T1c | Brachytherapy | - | - | Jul-10 | |||||
| Jan-08 |
68 |
4.7 |
7 |
T1c |
Brachytherapy |
0.50 |
ADT/Chemotherapy |
Aug-10 | |||||
| Mar-10 |
59 |
6.1 |
6 |
T1c |
Brachytherapy |
- |
- |
Jun-10 | |||||
| Aug-04 |
44 |
27.0 |
? |
T1c |
Brachytherapy |
- |
ADT/Surgery |
Jun-10 | |||||
|
Nov-04 |
58 |
10.4 |
6 |
T1b |
Brachytherapy |
0.10 |
No
problems |
Jan-10 | |||||
| Dec-09 |
72 |
0.30 |
7 |
T2a |
Brachytherapy/ADT |
0.10 |
Some
urinary issues |
Jul-10 | |||||
Oct-06 | 61 | 5.2 | 6 | T1c | 6.4 | - | Jun-10 | ||||||
| Jul-08 |
64 |
5.8 |
6 |
T1c |
HDR
Brachytherapy | 0.30 |
Daily
Cialis for ED |
Aug-10 | |||||
| Dec-04 |
66 |
6.1 |
6 |
T1c |
Brachytherapy | 0.03 |
- |
Jun-09 | |||||
| Apr-09 |
60 |
6.7 |
5 |
T1c |
Brachytherapy |
0.94 |
Some
libido/ED issues |
Apr-10 | |||||
May-07 | 59 | 115.0 | 7 | T2a | ADT/Brachytherapy | 4.2 | EBRT | Oct-09 | |||||
|
Primary
Treatment
|
Further
treatment, if any, with current PSA |
Name | |||||||||||
|
Date |
Age |
PSA |
GS |
Stage |
PSA |
Treatment/SideEffects
| Date | ||||||
CRYOTHERAPY | |||||||||||||
Apr-93 | 57 | 6.3 | 7 | T1c | Cryotherapy | <0.01 | Proton
Beam/No SE | Jul-10 | |||||
Jan-94 | 65 | 6.8 | 7 | T2b | Cryotherapy | 0.34 | ADT/Supplements
| Aug-09 | |||||
Jan-08 | 56 | 5.6 | 8 | T2 | Cryotherapy |
No
response to reminder | Jun-08 | ||||||
Apr-07 | 71 | 4.7 | 6 | T2 | Cryotherapy | 2.6 | AS/EBRT | Sep-09 | |||||
Mar-10 | 56 | 5.98 | 8 | T1c | Focal
Cryotherapy | - | - | Jul-10 | |||||
Jan-04 | 65 | 2.99 | 6 | T2c |
Cryotherapy | No
response to reminder | May-06 | ||||||
May-07 | 54 | 4.5 | 6 | T1c | Focal
Cryotherapy | 1.00 | Prostatitis | Aug-10 | |||||
Jan-08 | 64 | 7.5 | 7 | T1c | Cryotherapy | 0.10 | No
SE mentioned | Mar-10 | |||||
Aug-05 | 58 | 9.1 | 7 | T2a | Cryotherapy | 0.01 | - | Jul-09 | |||||